Arcus Biosciences (RCUS) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to 0.45.
- Arcus Biosciences' Equity Ratio rose 299.65% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 299.65%. This contributed to the annual value of 0.42 for FY2024, which is 4.23% down from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Equity Ratio is 0.45, which was up 299.65% from 0.51 recorded in Q2 2025.
- Arcus Biosciences' 5-year Equity Ratio high stood at 0.71 for Q1 2021, and its period low was 0.42 during Q4 2024.
- In the last 5 years, Arcus Biosciences' Equity Ratio had a median value of 0.51 in 2022 and averaged 0.51.
- Per our database at Business Quant, Arcus Biosciences' Equity Ratio crashed by 2736.35% in 2022 and then skyrocketed by 1406.07% in 2024.
- Arcus Biosciences' Equity Ratio (Quarter) stood at 0.53 in 2021, then fell by 4.45% to 0.51 in 2022, then decreased by 16.52% to 0.42 in 2023, then decreased by 0.04% to 0.42 in 2024, then grew by 6.14% to 0.45 in 2025.
- Its Equity Ratio stands at 0.45 for Q3 2025, versus 0.51 for Q2 2025 and 0.46 for Q1 2025.